| Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-Tube test in patients with immune-mediated inflammatory diseases. | |
| | |
MedLine Citation:
|
PMID: 22736247 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
To compare the tuberculin skin test (TST) and QuantiFERON-TB Gold In-Tube test (QFG) for the detection of latent tuberculosis infection among patients with immune-mediated inflammatory diseases before antitumor necrosis factor-α therapy. A prospective study including 153 consecutive patients with rheumatoid arthritis (n = 53), psoriasis (n = 45), inflammatory bowel disease (n = 25), and spondyloarthropathy (n = 22) were included. QFG and TST were performed simultaneously. TST was positive in 43/153 (28.1 %) patients. QFG (cutoff ≥ 0.35 IU/ml) was positive in 15/153 (9.8 %) patients, and indeterminate in one (0.7 %). QFG (cutoff ≥ 0.10 IU/ml) was positive in 25/153 (16.3 %). 59.5 % of the patients were on immunosuppressive therapy at the time of testing. There was a significant difference in the rate of positive QFG between patients with and without immunosuppressive therapy after adjustment for age and gender (cutoff ≥ 0.35 IU/ml, 4.6 vs. 17.4 %; adjusted odds ratio [AOR], 0.2; 95 % confidence interval [CI], 0.06-0.8; p = 0.03 and cutoff ≥ 0.10 IU/ml, 11.2 vs. 24.2 %; AOR, 0.3; 95 % CI, 0.1-0.93; p = 0.04). Agreement between TST and QFG was 'fair' (κ = 0.354 and κ = 0.365, for cutoffs ≥ 0.35 and ≥0.10 IU/ml, respectively). Among patients without immunosuppressive therapy, the concordance between TST and QFG was 'moderate-substantial' (κ = 0.593 and κ = 0.690, for cutoffs ≥ 0.35 IU/ml and ≥0.10 IU/ml, respectively). By contrast, among patients on immunosuppressive therapy the concordance was 'poor' (κ = 0.085; κ = 0.041, respectively). Immunosuppressive therapy affects negatively QFG performance. In patients with immune-mediated inflammatory diseases, QFG may have a limited role for screening of latent tuberculosis infection. |
| | |
Authors:
|
José M Ramos; Mar Masiá; Juan C Rodríguez; Cristina López; Sergio Padilla; Catalina Robledano; Francisco J Navarro-Blasco; Jaime Matarredona; Mariana F García-Sepulcre; Félix Gutiérrez |
Related Documents
:
|
16961947 - The role of the basal ganglia in the control of automatic visuospatial attention. 18230267 - The prevalence of carotid artery calcification on the panoramic radiographs of end-stag... 19117367 - Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical su... 21922187 - Omega-3 fatty acids in juvenile idiopathic arthritis: effect on cytokines (il-1 and tnf... 20506317 - Treg cell numbers and function in patients with antibiotic-refractory or antibiotic-res... 16961947 - The role of the basal ganglia in the control of automatic visuospatial attention. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-6-27 |
Journal Detail:
|
Title: Clinical and experimental medicine Volume: - ISSN: 1591-9528 ISO Abbreviation: - Publication Date: 2012 Jun |
Date Detail:
|
Created Date: 2012-6-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100973405 Medline TA: Clin Exp Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Infectious Diseases Unit, Hospital General Universitario de Elche, Camí de l'Almassara 11, 3203, Elche, Alicante, Spain, jramosrincon@yahoo.es. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Lysosomal membrane protein TMEM192 deficiency triggers crosstalk between autophagy and apoptosis in ...
Next Document: A simple method to clamp end-tidal carbon dioxide during rest and exercise.